Last update 10 Jun 2025

Human cord derived MSC cell (Guangzhou SALIAI Stemcell)

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms
SALIAI-UC1
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal Diseases
Active Indication
Osteoarthritis, Knee
Inactive Indication-
Originator Organization
Guangzhou SALIAI Stemcell Science & Technology Co., Ltd.Guangzhou SALIAI Stemcell Science & Technology Co., Ltd.
Active Organization
Guangzhou SALIAI Stemcell Science & Technology Co., Ltd.Guangzhou SALIAI Stemcell Science & Technology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Human cord derived MSC cell (Guangzhou SALIAI Stemcell)
CTR20222201
/ Active, not recruitingPhase 1
多中心、单次给药、剂量递增探索人脐带间充质干细胞注射液治疗膝骨关节炎的安全性、耐受性临床试验
[Translation] A multicenter, single-dose, dose-escalation clinical trial to explore the safety and tolerability of human umbilical cord mesenchymal stem cell injection in the treatment of knee osteoarthritis
NCT03237442
/ Unknown statusPhase 1/2
Placebo-Controlled,Randomized,Double-blind Trial of Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn
CTR20252104
/ Not yet recruitingPhase 2
人脐带间充质干细胞注射液治疗膝骨关节炎的多中心、随机、双盲、平行对照Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, parallel-controlled phase II clinical trial of human umbilical cord mesenchymal stem cell injection in the treatment of knee osteoarthritis
100 Clinical Results associated with Human cord derived MSC cell (Guangzhou SALIAI Stemcell)
Login to view more data
100 Translational Medicine associated with Human cord derived MSC cell (Guangzhou SALIAI Stemcell)
Login to view more data
100 Patents (Medical) associated with Human cord derived MSC cell (Guangzhou SALIAI Stemcell)
Login to view more data
100 Deals associated with Human cord derived MSC cell (Guangzhou SALIAI Stemcell)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Osteoarthritis, KneePhase 2
China
Guangzhou SALIAI Stemcell Science & Technology Co., Ltd.Guangzhou SALIAI Stemcell Science & Technology Co., Ltd.
19 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free